1232731

Exeltis USA, Inc. — FEI 3008163531

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 15, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Florham Park, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)